Related Experiment Videos
Iron deficiency and anaemia in heart failure: understanding the FAIR-HF trial
José González-Costello1, Josep Comín-Colet
1Heart Failure and Cardiac Transplant Unit, Department of Cardiology, Hospital Universitari de Bellvitge, Institut d'Investigació Biomédica de Bellvitge, Universitat de Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain. jgcostello@hotmail.com
Abstract:
Treatment of anaemia in patients with chronic heart failure (CHF) and reduced left ventricular ejection fraction has traditionally focused on erythropoietin-stimulating agents. However, recent studies have shown that treatment with intravenous (IV) iron can improve the symptoms and quality of life in patients with CHF and iron deficiency (ID), with or without anaemia. The management of ID is becoming an important therapeutic target in patients with CHF, and in this article, we will review iron metabolism in the context of anaemia and heart failure. We will also focus on the importance of diagnosing and treating ID, preferably with IV iron preparations, in patients with CHF.
Related Concept Videos
Heart Failure I: Introduction
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Heart Failure VII: Nursing Interventions
Heart Failure III: Clinical Manifestations
Heart Failure II: Pathophysiology